0001121795 true --06-30 2023 Q3 Amendment No 1 0001121795 2022-07-01 2023-03-31 0001121795 2023-05-11 0001121795 2023-03-31 0001121795 2022-06-30 0001121795 us-gaap:SeriesAPreferredStockMember 2023-03-31 0001121795 us-gaap:SeriesAPreferredStockMember 2022-06-30 0001121795 us-gaap:SeriesBPreferredStockMember 2023-03-31 0001121795 us-gaap:SeriesBPreferredStockMember 2022-06-30 0001121795 2023-01-01 2023-03-31 0001121795 2022-01-01 2022-03-31 0001121795 2021-07-01 2022-03-31 0001121795 GHST:PreferredStockSeriesAMember 2021-12-31 0001121795 GHST:PreferredStockSeriesBMember 2021-12-31 0001121795 us-gaap:CommonStockMember 2021-12-31 0001121795 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001121795 us-gaap:RetainedEarningsMember 2021-12-31 0001121795 2021-12-31 0001121795 GHST:PreferredStockSeriesAMember 2021-06-30 0001121795 GHST:PreferredStockSeriesBMember 2021-06-30 0001121795 us-gaap:CommonStockMember 2021-06-30 0001121795 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001121795 us-gaap:RetainedEarningsMember 2021-06-30 0001121795 2021-06-30 0001121795 GHST:PreferredStockSeriesAMember 2022-12-31 0001121795 GHST:PreferredStockSeriesBMember 2022-12-31 0001121795 us-gaap:CommonStockMember 2022-12-31 0001121795 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001121795 us-gaap:RetainedEarningsMember 2022-12-31 0001121795 2022-12-31 0001121795 GHST:PreferredStockSeriesAMember 2022-06-30 0001121795 GHST:PreferredStockSeriesBMember 2022-06-30 0001121795 us-gaap:CommonStockMember 2022-06-30 0001121795 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001121795 us-gaap:RetainedEarningsMember 2022-06-30 0001121795 GHST:PreferredStockSeriesAMember 2022-01-01 2022-03-31 0001121795 GHST:PreferredStockSeriesBMember 2022-01-01 2022-03-31 0001121795 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001121795 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001121795 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001121795 GHST:PreferredStockSeriesAMember 2021-07-01 2022-03-31 0001121795 GHST:PreferredStockSeriesBMember 2021-07-01 2022-03-31 0001121795 us-gaap:CommonStockMember 2021-07-01 2022-03-31 0001121795 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2022-03-31 0001121795 us-gaap:RetainedEarningsMember 2021-07-01 2022-03-31 0001121795 GHST:PreferredStockSeriesAMember 2023-01-01 2023-03-31 0001121795 GHST:PreferredStockSeriesBMember 2023-01-01 2023-03-31 0001121795 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001121795 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001121795 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001121795 GHST:PreferredStockSeriesAMember 2022-07-01 2023-03-31 0001121795 GHST:PreferredStockSeriesBMember 2022-07-01 2023-03-31 0001121795 us-gaap:CommonStockMember 2022-07-01 2023-03-31 0001121795 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2023-03-31 0001121795 us-gaap:RetainedEarningsMember 2022-07-01 2023-03-31 0001121795 GHST:PreferredStockSeriesAMember 2022-03-31 0001121795 GHST:PreferredStockSeriesBMember 2022-03-31 0001121795 us-gaap:CommonStockMember 2022-03-31 0001121795 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001121795 us-gaap:RetainedEarningsMember 2022-03-31 0001121795 2022-03-31 0001121795 GHST:PreferredStockSeriesAMember 2023-03-31 0001121795 GHST:PreferredStockSeriesBMember 2023-03-31 0001121795 us-gaap:CommonStockMember 2023-03-31 0001121795 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001121795 us-gaap:RetainedEarningsMember 2023-03-31 0001121795 2019-06-28 2019-06-29 0001121795 2019-06-29 0001121795 us-gaap:PatentsMember 2023-03-31 0001121795 us-gaap:PatentsMember 2022-06-30 0001121795 2021-09-29 2021-09-30 0001121795 us-gaap:InvestorMember 2021-07-01 2022-06-30 0001121795 us-gaap:InvestorMember 2022-06-30 0001121795 2021-08-06 2021-08-07 0001121795 2021-08-07 0001121795 2023-02-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Amendment No. 1 

FORM 10-Q/A

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2023

 

Or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to ___________

 

Commission file number: 000-31705

 

GHST World Inc.
(Exact name of registrant as specified in charter)

 

Delaware   91-2007477
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)
     

667 Madison Avenue 5th Floor

New York, NY

  10065
(Address of principal executive offices)   (Zip Code)

 

+1 (212) 634-6860
(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by checkmark whether the registrant has (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No

 

Indicate by checkmark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act..

 

  Large accelerated filer Accelerated filer
  Non-accelerated filer Smaller reporting company
      Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standard provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No

 

As of May 11, 2023, the issuer had 125,255,403 shares of its common stock, $0.001 par value per share, outstanding.

 
 

 

 
 

 

 

Explanatory Note

 

This Amendment No. 1 on Form 10-Q/A (this “Amendment”) amends the Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023 (the “Form 10-Q”) of GHST World Inc. (the “Company”), as filed with the Securities and Exchange Commission (the “SEC”) on May 12, 2023. The Company is filing this Amendment to (i) correct various financial data in the financial statements contained in Part I. – Item 1 – Financial Information, particularly accumulated deficit and total stockholders’ deficit in the Consolidated Balance Sheet as of June 30, 2022, General and administrative expenses, depreciation and amortization, total operating expenses, Net Loss and Weighted average number of common shares outstanding in the Consolidated Statement of Operations for the three months ended March 31, 2023, and Cash Flows from Financing Activities in the Consolidated Statement of Cash Flows for the nine months ended March 31, 2022, together with changes to Note 7 – Stockholders’ Equity and Note 9 – Subsequent Events in the footnotes to such financial statements, (ii) include in Part I. - Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations – in the Form 10-Q which section was excluded from the original filing, (iii) correct the number of shares outstanding as of May 11, 2023 reflected on the cover page, (iv) correct Part I – Item 4 – Controls and Procedures to refer to the period ended March 31, 2023, and (v) add disclosure to Part II under Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds and Item 5 – Other Information. Each of these discrepancies resulted from an error made by the Electronic Data Gathering, Analysis, and Retrieval (“EDGAR”) filing agent in the submission of the original filing of the Form 10-Q with the SEC’s EDGAR system.

 

In addition, the Exhibit Index in Item 6 of Part II of the Form 10-Q is hereby amended and restated in its entirety and currently dated certifications required under Section 302 and Section 906 of the Sarbanes-Oxley Act of 2002 are filed as exhibits to this Amendment.

 

The Form 10-Q as amended hereby continues to speak as of the date on which the Form 10-Q was initially filed, and we have not updated the disclosures contained therein to reflect any events which occurred at a date subsequent to the initial filing of the Form 10-Q other than as expressly indicated in this Amendment.

 

 

 

 

 
 

 

 

TABLE OF CONTENTS

 

    Page
  PART I - Financial Information  
     
Item 1 Financial Statements 1
  Consolidated Balance Sheets – As of March 31, 2023 (Unaudited) and June 30, 2022 1
  Consolidated Statements of Comprehensive Loss (Unaudited) – For the Three and Nine Months Ended March 31, 2023 and 2022 2
  Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) – For the Three and Nine Months Ended March 31, 2023 and 2022 3
  Consolidated Statements of Cash Flows (Unaudited) – For the Nine Months Ended March 31, 2023 and 2022 4
  Condensed Notes to Consolidated Financial Statements (Unaudited) 5
     
Item 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations 9
Item 3 Quantitative and Qualitative Disclosures About Market Risk 11
Item 4 Controls and Procedures 12
     
  Part II - Other Information  
     
Item 1 Legal Proceedings 13
Item 1A Risk Factors 13
Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 13
Item 3 Defaults Upon Senior Securities 13
Item 4 Mine Safety Disclosures 13
Item 5 Other Information 13
Item 6 Exhibits 14
     
Signatures 15

 

 

 

 

 

 

 

i 
 

 

PART I: FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

  

GHST World Inc.

Consolidated Balance Sheets

 

         
   March 31, 2023   June 30, 2022 
   (Unaudited)     
Assets
         
Current Assets          
Cash  $539   $206 
Total Current Assets   539    206 
           
           
Other assets         115,000 
Patent costs, net   40,362    39,181 
           
Total Assets  $40,901   $154,387 
           
Liabilities and Stockholders’ Deficit          
           
Current Liabilities          
Accounts payable and accrued expenses  $2,795   $1,685 
Advances from related parties   93,362   $75,446 
Common stock payable   9,559    9,559 
Total Current Liabilities   105,716    86,690 
           
Commitments and Contingencies (Note 8)            
           
Stockholders’ Deficit          
Preferred stock, $0.001 par value; 10,000,000 shares authorized;          
     Series A, 6,000 shares issued and outstanding   6    6 
     Series B, 2,200 shares issued and outstanding   2    2 
Common stock, $0.001 par value, 300,000,000 shares authorized; 125,255,403 and 124,430,534 shares issued at March 31, 2023 and June 30,2022   125,255    124,431 
Additional paid-in-capital   9,436,315    9,362,205 
Accumulated deficit   (9,626,393)   (9,418,947)
Total Stockholders’ Deficit   (64,815)   67,697 
           
Total Liabilities and Stockholders' Deficit  $40,901   $154,387 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

1 
 

 

GHST World Inc.

Consolidated Statements of Operations

(Unaudited)

 

                 
   For the Three Months Ended March 31   For the Nine Months Ended March 31 
   2023   2022   2023   2022 
                 
Revenues  $     $     $     $   
                     
Operating expenses:                    
General and administrative expenses   21,286    23,948    89,449    104,196 
Product development costs                     10,569 
Depreciation and Amortization   1,598          2,997       
Total operating expenses   22,884    23,948    92,446    114,765 
                     
Other Income(expense):                    
Interest Expense                  (150)
Loss on change in fair value of debts                  (1,700)
Impairment of long-lived assets               (115,000)      
Total Other Income (expense)               (115,000)   (1,850)
                     
Net loss  $(22,884)  $(23,948)  $(207,446)  $(116,615)
                     
                     
Net loss per common share                    
Basic  $(0.00)  $(0.00)  $(0.00)  $(0.00)
Diluted  $(0.00)  $(0.00)  $(0.00)  $(0.00)
                     
Weighted average number of common shares outstanding                    
Basic   125,239,107    82,423,684    124,967,075    30,717,015 
Diluted   125,239,107    82,423,684    124,967,075    30,717,015 

 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

2 
 

 

GHST World Inc.

Consolidated Statement of Changes in Stockholders' Equity (Deficit)

For the Three and Nine Months Ended March 31, 2023, and 2022

(Unaudited)

  

                                              
   Preferred Stock Series A   Preferred Stock Series B   Common Stock $0.001 Par Value   Additional Paid in   Accumulated   Total Stockholders' 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
                                     
Balance December 31,2021   6,000   $6    2,200   $2    54,137,647   $54,138   $9,246,631   $(9,359,730)  $(58,953)
Issuance of common stock in exchange for debt   —     $      —            69,863,296    69,863    59,383          129,246 
Issuance of common stock for cash                       38,666    39    5,762          5,801 
Net loss for the three months ended March 31, 2022   —            —            —                  (23,948)   (23,948)
Balance March 31, 2022   6,000   $6    2,200   $2    124,039,609   $124,040   $9,311,776   $(9,383,678)  $52,146 
                                              
Balance June 30, 2021   6,000   $6    2,200   $2    5,239,832   $5,240   $9,174,792   $(9,267,062)  $(87,022)
Issuance of common stock in exchange for debt                       118,663,761    118,664    106,595          225,259 
Issuance of common stock for cash                       136,016    136    30,389          30,525 
Net loss for the nine months ended March 31, 2022                                      (116,615)   (116,615)
Balance March 31, 2022   6,000   $6    2,200   $2    124,039,609   $124,040   $9,311,776   $(9,383,677)  $52,147 
                                              
Balance December 31,2022   6,000   $6    2,200   $2    125,222,070   $125,222   $9,434,348   $(9,603,736)  $(44,158)
Issuance of common stock for cash   —            —            33,333    33    1,967          2,000 
Net loss for the three months ended March 31, 2023   —            —            —                  (22,657)   (22,657)
Balance March 31, 2023   6,000   $6    2,200   $2    125,255,403   $125,255   $9,436,315   $(9,626,393)  $(64,815)
                                              
Balance June 30, 2022   6,000    6    2,200    2    124,430,534    124,431    9,362,205    (9,418,947)   67,697 
Issuance of common stock for cash                      824,869    824    74,110         74,934 
Net loss for the nine months ended March 31, 2023                                      (207,446)   (207,446)
Balance March 31, 2023   6,000   $6    2,200   $2    125,255,403   $125,255   $9,436,315   $(9,626,393)  $(64,815)

 

 

The accompanying notes are an integral part of these consolidated financial statements.

  

 

3 
 

 

GHST World Inc.

Consolidated Statements of Cash Flows

(Unaudited)

 

         
   For the Nine Months Ended March 31, 
   2023   2022 
         
CASH FLOWS FROM OPERATING ACTIVITIES          
Net loss  $(207,446)  $(116,615)
Adjustments to reconcile net loss to net cash used in operating activities:          
Loss on change in fair value of debt        1,700 
Impairment of long-lived assets   115,000       
Amortization   2,997       
Changes in operating assets and liabilities:          
Accounts payable and accrued expenses   1,110    1,214 
Net Cash Used In Operating Activities   (88,339)   (113,701)
           
CASH FLOWS  FROM INVESTING ACTIVITIES          
Patent costs   (4,178)      
Net Cash Used In Investing Activities   (4,178)      
           
CASH FLOWS FROM FINANCING ACTIVITIES          
Advances from related parties   17,916    60,854 
Increase in common stock payable         15,334 
Issuance of common stock for cash   74,934    30,525 
Net Cash Provided By Financing Activities   92,850    106,713 
           
Net increase (decrease) in cash   333    (6,988)
           
Cash - beginning of period   206    7,350 
           
Cash - end of period  $539   $362 
           
SUPPLEMENTARY DISCLOSURE OF CASH FLOW INFORMATION:          
Cash paid during the year/period for:          
Interest  $     $   
Taxes  $     $   
           
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:          
           
Issuance of common stock in exchange for debt  $     $225,259 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

 

4 
 

 

 

GHST WORLD, INC.

Condensed Notes to Consolidated Financial Statements

March 31, 2023 and June 30, 2022

(Unaudited)

 

NOTE 1- ORGANIZATION, DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

 

Background

 

GHST World Inc. (“the Company”), is a Delaware corporation that was incorporated on November 12, 1999.

 

The Company is a holding company for various technology and other activities. The Company has acquired and is developing several patents in the technology sector.

 

Basis of Presentation

 

The interim unaudited financial statements included herein have been prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission. In management's opinion, all adjustments (consisting of normal recurring adjustments and reclassifications) necessary to present fairly our results of operations and cash flows for the three and nine months ended March 31, 2023 and 2022, and our financial position as of March 31, 2023, have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year.

 

Certain information and disclosures normally included in the notes to the annual financial statements have been condensed or omitted from these interim financial statements. Accordingly, these interim unaudited financial statements should be read in conjunction with the financial statements and notes thereto for the year ended June 30, 2022.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Liquidity and Going Concern

 

The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company had net losses of $207,446 and $116,615 for the nine months ended March 31, 2023 and 2022. The Company has an accumulated deficit of $9,626,393 and a stockholders ‘deficit of $64,815 as of March 31, 2023 and used $88,339 and $113,701 in cash flow from operating activities for the nine months ended March 31, 2023 and 2022.

 

Management believes these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the next twelve months from the date these financial statements were issued. The ability to continue as a going concern is dependent upon profitable future operations, positive cash flows, and additional financing. These financial statements do not include any adjustments related to the recovery and classification of recorded asset amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Management intends to raise money through investors as needed to support its working capital needs. Currently the Company intends to raise capital from its existing shareholders. Management cannot provide any assurances that the Company will be successful in completing these undertakings and accomplishing any of its plans.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the following inactive wholly owned subsidiaries:

 

·GHST Art World, Inc
·GHST Sport Inc.
·IoTT world Inc.

 

All intercompany balances and transactions have been eliminated in consolidation.

 

5 

GHST WORLD, INC.

Condensed Notes to Consolidated Financial Statements

March 31, 2023 and June 30, 2022

(Unaudited)

 

 

Concentration of Credit Risk

 

The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash. The Company places its cash with financial institutions of high credit worthiness. At times, its cash with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it is a credit counterparty, and as such, it believes that any associated credit risk exposures are limited.

 

Foreign Currency

 

Transaction gains and losses are recognized in earnings. The Company is subject to foreign exchange rate fluctuations in connection with the Company’s international transactions as certain vendor payments and repayments of related party advances are done in foreign currency.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

 

Such estimates and assumptions impact, among others, the following: the valuation of other assets and patents, the fair value of share-based payments and deferred taxes.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.

 

Cash

Cash are amounts held at banks. The Company had no cash equivalents at March 31, 2023 or 2022.

Risks and Uncertainties

The Company is undertaking a new business venture that is inherently subject to significant risks and uncertainties, including financial, operational, technological and other risks that could potentially have a risk of business failure.

Fair Value

The carrying value of cash, other asset, accounts and other payable approximate their fair value based on the liquidity or the short-term maturities of these instruments. The fair value hierarchy promulgated by GAAP consists of three levels:

 

·Level one — Quoted market prices in active markets for identical assets or liabilities;
·Level two — Inputs other than level one inputs that are either directly or indirectly observable; and
·Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

 

Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company has no assets or liabilities that are measured at fair value on a recurring and/or non-recurring during the nine months ended March 31, 2023 and 2022.

 

6 

GHST WORLD, INC.

Condensed Notes to Consolidated Financial Statements

March 31, 2023 and June 30, 2022

(Unaudited)

 

 

 

Intangible Assets

 

The Company capitalizes external costs, such as filing fees and associated attorney fees, incurred to obtain issued patents and patent license rights. The Company expenses costs associated with maintaining and defending patents subsequent to their issuance in the period incurred. Once a patent is granted, the Company will amortize capitalized patent costs for internally generated patents on a straight-line basis over seven years, which represents the estimated useful lives of the patents. Amortization is recorded on a straight-line basis over the seven-year estimated useful life. The seven-year estimated useful life for internally generated patents is based on management’s assessment of such factors as the integrated nature of the portfolios being licensed, the overall makeup of the portfolio over time, and the length of license agreements for such patents. The Company assesses the potential impairment to all capitalized net patent cost when events or changes in circumstances indicate that the carrying amount of its patent portfolio may not be recoverable. 

Impairment of Long-Lived Assets

 

The Company accounts for impairment of long-lived assets in accordance with Accounting Standards Codification (“ASC”) 360, Property, Plant and Equipment, (“ASC 360”). Long-lived assets for the Company consist primarily of other assets and patents. In accordance with ASC 360, the Company periodically evaluates long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When triggering event indicators are present, the Company obtains appraisals on an asset by asset basis and will recognize an impairment loss when the sum of the appraised values is less than the carrying amounts of such assets. The appraised values, based on reasonable and supportable assumptions and projections, require subjective judgments. Depending on the assumptions and estimates used, the appraised values projected in the evaluation of long-lived assets can vary within a range of outcomes. The appraisals consider the likelihood of possible outcomes in determining the best estimate for the value of the assets. 

Income Taxes

 

Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and the respective tax bases. Deferred tax assets, including tax loss and credit carryforwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The effect of income tax positions is recognized only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.

 

7 

GHST WORLD, INC.

Condensed Notes to Consolidated Financial Statements

March 31, 2023 and June 30, 2022

(Unaudited)

 

 

 

Stock Based Compensation

 

The Company applies the fair value method of ASC 718, Share Based Payment, in accounting for its stock-based compensation. This accounting standard states that compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period, if any. As the Company does not have sufficient, reliable, and readily determinable values relating to its common stock, the Company has used the stock value pursuant to its most recent sale of stock for purposes of valuing stock-based compensation.

Net Loss Per Share

 

Basic net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the periods presented. Diluted net loss per common share is computed using the weighted average number of common shares outstanding for the period, and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options, stock warrants, convertible debt instruments or other common stock equivalents. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive.. The Company had no potentially dilutive securities outstanding for the three and six months ended March 31, 2023 or 2022.

 

Recent Accounting Pronouncements

 

There are no other recent accounting pronouncements that are expected to have a material effect on the Company's financial statements.

 

NOTE 3 – OTHER ASSETS

 

On June 29, 2019, the Company acquired all the stock of GHST Art World, Inc, a Florida corporation, whose primary assets consisted of 119 art paintings and reproductions. The Company issued 43,478,000 shares of common stock and paid $15,000 in cash to effectuate the acquisition. The Company valued the stock at the fair market value of the stock on the date of issuance or approximately $0.0023 per share for a total purchase price of $115,000. The entire purchase price was allocated to the art and no goodwill was recorded.

 

On September 30, 2022, the Company’s management determined that the carrying value of the assets are impaired as there has been no third-party sales of such art work since acquisition and the planned business activity relating to such art work has been delayed. As a result, the Company has recorded an impairment loss of $115,000 for the six months ended March 31, 2023.

 

NOTE 4 – PATENTS

 

The Company obtained a patent dated June 30, 2020, which is a protection device used in sporting activity with the capability to monitor data from the device. The Company has capitalized the patent costs totaling $40,362 and $39,181 as of March 31, 2023, and June 30, 2022. The Company started amortizing the patent during the three months ended December 31, 2022 over the seven-year useful life of the patent. Amortization was $2,998 was recorded for the three months ended March 31, 2023.

 

Schedule of patents        
   March 31, 2023   June 30,
2022
 
Patents  $43,359   $39,181 
Accumulated amortization   2,997     
Patents, net  $40,362   $39,181 

 

 

8 

GHST WORLD, INC.

Condensed Notes to Consolidated Financial Statements

March 31, 2023 and June 30, 2022

(Unaudited)

 

 

 

NOTE 5 – COMMON STOCK PAYABLE

 

The Company has an agreement with certain investors to convert their investment into common stock of the Company at a price equal to the average value of the stock over the previous six months. The conversion was contingent on the Company effectuating a 1-for-100 reverse stock split which was effected on September 30, 2021. As of March 31, 2023, and June 30, 2022, the Company has a total of $9,559 that has not been converted to common stock.

 

During the year ended June 30, 2022 certain investors accepted a total of 118,663,761 shares at an average price of approximately $0.0019 in exchange for $225,259 of debt which was classified as common stock payable.

NOTE 6 – RELATED PARTY TRANSACTIONS

 

At March 31, 2023 and June 30, 2022, the Company owed related parties a total of $93,362 and $75,446, respectively. These shareholder loans are unsecured, non-interest bearing and are due on demand.

 

As shown in Note 5, the Company has committed to converting certain debts to equity. Included in the debts is $9,559 as of March 31, 2023, of amounts due to related parties that will be converted as described in Note 5.

 

NOTE 7 – STOCKHOLDERS’ EQUITY

 

On August 7, 2021, the board approved amending its articles of incorporation to reduce the number of authorized shares from 700,000,000 to 310,000,000 of which 300,000,000 are reserved for common stock and 10,000,000 for preferred stock.

 

Common Stock Issuances

 

During the nine months ended March 31, 2023, the Company issued 824,869 shares in exchange for $74,934 at an average price of $0.09.

 

NOTE 8. COMMITMENTS AND CONTINGENCIES

 

Legal Matters

 

From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of March 31, 2023, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the result of our operations.

 

On February 7, 2023, the Company entered into an agreement with a vendor to develop the technology associated with the Company’s patent for shin guards used in sports. The contract was for $46,000, but management decided to cancel the contract in favor of other potential vendors that the Company is studying closely.

 

NOTE 9 – SUBSEQUENT EVENTS

The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements were issued for potential recognition or disclosure. Other than below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated financial statements. In April 2023 the Company formed a new wholly-owned subsidiary, InSSIDe World, Inc.

 

 

 

 

 

9 
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

 

Overview

 

We are a holding company for various technology and related activities. As of the date of this Quarterly Report on Form 10-Q (this “Report”), our principal business strategy is seeking to exploit a patent and obtain and exploit future patents for the Smart Shin Guard. The Smart Shin Guard is a wearable protective device used while playing soccer and certain other sports combined with data collection and analysis technology that monitors players’ individual and collective physical and performance-based metrics and transmits this information to a separate module in real-time.

 

We have not generated any revenue and need substantial additional financing to market our services. In the fiscal year ended June 30, 2021 we filed a registration statement on Form 10 with the SEC, which became effective May 8, 2021 (the “Form 10”), pursuant to which we became subject to the periodic and current reporting requirements under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”).

 

Recent Developments

 

On March 10, 2023, we terminated our agreement with Hemar AG, which agreement provided for the development of artificial intelligence capabilities for our Smart Shin Guard product. We are currently seeking vendors to further develop the Smart Shin Guard with the goal of marketing the product later in 2023. To do so, we need to complete the development process for the product, which may entail, among other things, further addressing its potential artificial intelligence capabilities. We are also in search of other strategic alliances and potential business opportunities to develop and enhance our business plan and intended product offerings.

 

In April 2023, the Company incorporated InSSIDe World Inc., a Florida corporation and wholly-owned subsidiary of the Company, as a development-stage business which is intended to be focused on intelligence, security, strategic infrastructure and defense.

Results of Operations

The following discussion should be read in conjunction with the financial statements and notes thereto included elsewhere in this report.

Fiscal Quarter Ended March 31, 2023 Compared to the Fiscal Quarter Ended March 31, 2022

We had no revenues in the three months ended March 31, 2023 and 2022, and we sustained net losses of $22,884 and $23,948, respectively, in those periods. During the three months ended March 31, 2023 and 2022, expenses consisted primarily of general and administrative expenses, including professional fees for legal and financial services. The decline in operating expenses related to termination of our previous agreement with Hemar AG, although we are in discussions with prospective new AI vendors to further develop our Smart Shin Guard Product.

Nine Months Ended March 31, 2023 Compared to the Nine Months Ended March 31, 2022

We had no revenues in the nine months ended March 31, 2023 and 2022, and we sustained net losses of $207,446 and $116,615, respectively, in those periods.

Our total operating expenses were $92,446 and $114,765 during the nine months ended March 31, 2023 and 2022, respectively reflecting a decrease in general and administrative expenses of $14,747 between periods, partially offset by the lack of product development costs in the 2023 period compared to $10,569 of such costs in the 2022 period.

We do not expect to generate material revenue unless and until we can implement our business plan and begin marketing and selling our product(s) in sufficient quantities, which was previously delayed due to COVID-19 impacts on our development efforts and on league play which adversely affected our product development capabilities. We may encounter further delays, as we terminated our prior agreement to develop certain technology related to our Smart Shin Guard, and our currently in search of collaboration partners and strategic alliances and transactions to further advance our products and advance our business.

We also may encounter difficulties commercializing our product(s) in the future based on supply chain issues, inflation and adverse market conditions which may result. In order to become profitable, we will need to establish a sufficient market for our product, including internationally, to offset our development, manufacturing and advertising costs, and our ability to do so will be subject to a number of factors, many of which will be beyond our control.

 

10 
 

Liquidity and Capital Resources

Net Cash used by Operating Activities:

For the nine months ended March 31, 2023, the Company used net cash of $88,339 in operating activities as compared to $113,701 for the nine months ended March 31, 2022. The decrease in cash used from operations was primarily due to a one-time impairment of long-lived assets of $115,000 in the 2023 period related to previously purchased art work, with no related item in in the 2022 period, partially offset by decrease in professional fees and compliance costs in the 2023 period. We anticipate sustained or increased operational expenses as we transition our focus from product development to production and marketing efforts, which is expected to begin later in 2023 assuming our product development goals are met and testing yields satisfactory results. We also may experience higher costs as we pursue new potential business ventures, such as any new business we may pursue through InSSIDe World Inc. as described above, and potentially other business pursuits.

Cash Used in Investing Activities:

For the nine months ended March 31, 2023 and 2022, the Company used $4,178 and $0 in investing activities.

Cash Flows from Financing Activities:

Cash flows provided by financing activities for the nine months ended March 31, 2023 were $92,850 compared to $106,713 for the nine months ended March 31, 2022. The difference between periods is primarily attributable to subscriptions for common stock totaling $30,525 in the 2022 period compared to $74,934 in the 2023 period, partially offset by a decrease in advances from related parties in the 2023 period when compared to the prior period.

Liquidity

We have $539 in available cash as of March 31, 2023 and for the past two years we have been relying on loans from our current investors and related parties and proceeds from sales of our common stock to fund our operations. As reflected in the financial statements contained in this Report, management has expressed substantial doubt about our ability to continue as a going concern for the next 12 months from the date the financial statements were issued, unless we can raise the required capital or generate material revenue to fund our operations.

The Company expects to continue to use a portion of the authorized but unissued shares to raise capital and/or to convert previous loans made to the Company. During the three months ended March 31, 2023, the Company sold 33,333 shares of common stock at a purchase price of $0.06 per share, for total gross proceeds of $2,000.

Cautionary Note Regarding Forward Looking Statements

This Report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the development of the Smart Shin Guard and plans to begin commercializing the product in 2023, the planned operation of InSSIDe World Inc. as a development-stage business with a focus on intelligence, security, strategic infrastructure and defense, our pursuit of other strategic partnerships and business opportunities to enhance of product offerings and operations, the implementation of our business plan and expected timelines for meeting objectives, our use of common stock in capital raising efforts and to satisfy previous advances to us, and our liquidity. Forward-looking statements can be identified by words such as “anticipates,” “intends,” “plans,” “seeks,” “believes,” “estimates,” “expects” and similar references to future periods.

Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you therefore against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. The results anticipated by any or all of these forward-looking statements might not occur. Important factors, uncertainties and risks that may cause actual results to differ materially from these forward-looking statements include the risks arising from the potential adverse effects of inflation, increasing interest rates in response and an economic downturn or recession which may result, which may result in declines in consumer spending particularly to non-essential products such as the Smart Shin Guard, global supply chain disruptions, shortages and delays which may adversely affect our ability to develop, manufacture and sell our products within the intended timeframes or at all, risks and uncertainties surrounding new business opportunities we pursue, and the risks summarized our Annual Report on Form 10-K for the fiscal year ended June 30, 2022 in the section titled “Item 1A. – Risk Factors.” We undertake no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events or otherwise.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

 

 11

 

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officers, of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act as of the end of the period covered by this Report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officers have concluded that our disclosure controls and procedures as of March 31, 2023 were not effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms because of a material weakness in the Company’s internal control over financial reporting. Specifically, the Company did not maintain effective controls to identify and maintain segregation of duties to support the identification, authorization, approval, accounting for, and the disclosure of related-party transactions and non-routine transactions. One individual, the Chief Executive Officer, initiates related-party transactions and non-routine transactions and also reviews, evaluates and approves these same transactions.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting as defined in Rule 13a-15(f) or 15d-15(f) under the Exchange Act that occurred during the period covered by this Report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 

 

 12

 

 

 

PART II: OTHER INFORMATION

 

ITEM 1 - LEGAL PROCEEDINGS

 

From time-to-time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of the date of this Report, we are not aware of any other pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of our operations and there are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

 

ITEM 1.A – RISK FACTORS

 

Not applicable.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On February 3, 2023, the Company sold 33,333 shares of common stock at a purchase price of $0.06 per share, for total gross proceeds of $2,000.

The above transaction was exempt from registration under Section 4(a)(2) under the Securities Act of 1933 (the “Securities Act”), and under Regulation S of the Securities Act as the shares were issued in a transaction not involving a public offering or in an offshore transaction to persons who are not U.S. Persons as defined by Regulation S, and there were no directed selling efforts made in the United States.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5 - OTHER INFORMATION

 

On March 10, 2023, we terminated our agreement with Hemar AG, which agreement provided for the development of artificial intelligence capabilities for our Smart Shin Guard product. The agreement was previously filed as Exhibit 10.2 to our Registration Statement on Form 10-12G.

 

 

 13

 

 

 

ITEM 6 – EXHIBITS

 

        Incorporated by Reference  

Filed or

Furnished

Exhibit #   Exhibit Description   Form   Date   Number   Herewith
3.1   Amended and Restated Certificate of Incorporation   10-12G   3/9/2021   3.1    
3.2   Certificate of Amendment to Certificate of Incorporation (Reverse Stock Split)   10-Q   11/15/21   3.2    
3.3   Certificate of Amendment to Certificate of Incorporation (Decrease in Authorized Capital)   10-Q   11/15/2021   3.3    
3.4   Certificate of Designation   10-K   2/18/2010   3.3    
3.5   Amended and Restated Bylaws   10-12G   3/9/2021   3.3    
31.1   Certification of Principal Executive Officer (302)               Filed
31.2(a)   Certification of Principal Financial Officer (302)               Filed
31.2(b)   Certification of Principal Financial Officer (302)               Filed
32.1   Certification of Principal Executive and Principal Financial Officers (906)               Furnished*
101.INS   Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)               Filed
101.SCH   Inline XBRL Taxonomy Extension Schema Document               Filed
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document               Filed
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document               Filed
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document               Filed
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document               Filed
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)               Filed

 

 

*This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.

      

Copies of the exhibits referred to above will be furnished at no cost to our shareholders who make a written request to GHST World Inc., 667 Madison Avenue, 5th Floor, New York, NY 10065.

 

 

 

 

 

14 
 

  

SIGNATURES

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

    GHST World Inc.
     
Dated:  September 1, 2023 By:    /s/ Edoardo Riboli
      Edoardo Riboli,Chief Executive Officer
     

(Principal Executive Officer)

 

  

Dated:  September 1, 2023 By: /s/ Marcello Appella
      Marcello Appella, Chief Financial Officer
     

(Principal Financial Officer)

 

 

Dated:  September 1, 2023 By: /s/ Paolo Sangiovanni
      Paolo Sangiovanni, Chief Financial Officer
     

(Principal Financial Officer)

 

 

 

 

 

 

 

 15

 

 

 

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

 

I, Edoardo Riboli, certify that:

 

1.       I have reviewed this quarterly report on Form 10-Q/A of GHST World Inc.;

 

2.       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.       Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.       The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.       Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.       Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.       Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.       The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.       Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: September 1, 2023

 

/s/ Edoardo Riboli

Edoardo Riboli

Chief Executive Officer

(Principal Executive Officer)

 

 

 

 

 

Exhibit 31.2(a)

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

 

I, Marcello Appella, certify that:

 

1.       I have reviewed this quarterly report on Form 10-Q/A of GHST World Inc.;

 

2.       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.       Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.       The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.       Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.       Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.       Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.       The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.       Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: September 1, 2023

 

/s/ Marcello Appella

Marcello Appella

Chief Financial Officer

(Principal Financial Officer)

 

 

 

Exhibit 31.2(b)

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

 

I, Paolo Sangiovanni, certify that:

 

1.       I have reviewed this quarterly report on Form 10-Q/A of GHST World Inc.;

 

2.       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.       Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.       The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.       Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.       Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.       Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.       Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.       The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.       All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.       Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: September 1, 2023

 

/s/ Paolo Sangiovanni

Paolo Sangiovanni

Chief Financial Officer

(Principal Financial Officer)

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of GHST World Inc. (the “Company”) on Form 10-Q/A for the quarter ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof, I, Edoardo Riboli, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

1.The quarterly report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

 

2.The information contained in the quarterly report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

/s/ Edoardo Riboli

Edoardo Riboli

Chief Executive Officer

(Principal Executive Officer)

Dated: September 1, 2023

 

 

In connection with the quarterly report of GHST World, Inc. (the “Company”) on Form 10-Q/A for the quarter ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof, I, Marcello Appella, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

1.The quarterly report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

 

2.The information contained in the quarterly report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

/s/ Marcello Appella

Marcello Appella

Chief Financial Officer

(Principal Financial Officer)

Dated: September 1, 2023

 

 

In connection with the quarterly report of GHST World, Inc. (the “Company”) on Form 10-Q/A for the quarter ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof, I, Paolo Sangiovanni, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

1.The quarterly report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

 

2.The information contained in the quarterly report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

/s/ Paolo Sangiovanni

Paolo Sangiovanni

Chief Financial Officer

(Principal Financial Officer)

Dated: September 1, 2023

 

 

v3.23.2
Cover - shares
9 Months Ended
Mar. 31, 2023
May 11, 2023
Cover [Abstract]    
Document Type 10-Q/A  
Amendment Flag true  
Amendment Description Amendment No 1  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2023  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --06-30  
Entity File Number 000-31705  
Entity Registrant Name GHST World Inc  
Entity Central Index Key 0001121795  
Entity Tax Identification Number 91-2007477  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 667 Madison Avenue  
Entity Address, Address Line Two 5th Floor  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10065  
City Area Code 212  
Local Phone Number 634-6860  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period true  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   125,255,403
v3.23.2
Consolidated Balance Sheets - USD ($)
Mar. 31, 2023
Jun. 30, 2022
Current Assets    
Cash $ 539 $ 206
Total Current Assets 539 206
Other assets 115,000
Patent costs, net 40,362 39,181
Total Assets 40,901 154,387
Current Liabilities    
Accounts payable and accrued expenses 2,795 1,685
Advances from related parties 93,362 75,446
Common stock payable 9,559 9,559
Total Current Liabilities 105,716 86,690
Commitments and Contingencies (Note 8)
Stockholders’ Deficit    
Common stock, $0.001 par value, 300,000,000 shares authorized; 125,255,403 and 124,430,534 shares issued at March 31, 2023 and June 30,2022 125,255 124,431
Additional paid-in-capital 9,436,315 9,362,205
Accumulated deficit (9,626,393) (9,418,947)
Total Stockholders’ Deficit (64,815) 67,697
Total Liabilities and Stockholders' Deficit 40,901 154,387
Series A Preferred Stock [Member]    
Stockholders’ Deficit    
Preferred stock value 6 6
Series B Preferred Stock [Member]    
Stockholders’ Deficit    
Preferred stock value $ 2 $ 2
v3.23.2
Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2023
Jun. 30, 2022
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000,000 10,000,000
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 125,255,403 124,430,534
Common stock, shares outstanding 125,255,403 124,430,534
Series A Preferred Stock [Member]    
Preferred stock, shares issued 6,000 6,000
Preferred stock, shares outstanding 6,000 6,000
Series B Preferred Stock [Member]    
Preferred stock, shares issued 2,200 2,200
Preferred stock, shares outstanding 2,200 2,200
v3.23.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]        
Revenues
Operating expenses:        
General and administrative expenses 21,286 23,948 89,449 104,196
Product development costs 10,569
Depreciation and Amortization 1,598 2,997
Total operating expenses 22,884 23,948 92,446 114,765
Other Income(expense):        
Interest Expense       (150)
Loss on change in fair value of debts       (1,700)
Impairment of long-lived assets (115,000)
Total Other Income (expense) (115,000) (1,850)
Net loss $ (22,884) $ (23,948) $ (207,446) $ (116,615)
Net loss per common share        
Basic $ (0.00) $ (0.00) $ (0.00) $ (0.00)
Diluted $ (0.00) $ (0.00) $ (0.00) $ (0.00)
Weighted average number of common shares outstanding        
Basic 125,239,107 82,423,684 124,967,075 30,717,015
Diluted 125,239,107 82,423,684 124,967,075 30,717,015
v3.23.2
Consolidated Statement of Changes in Stockholders' Equity (Deficit) - USD ($)
Preferred Stock Series A [Member]
Preferred Stock Series B [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Jun. 30, 2021 $ 6 $ 2 $ 5,240 $ 9,174,792 $ (9,267,062) $ (87,022)
Shares, Outstanding, Beginning Balance at Jun. 30, 2021 6,000 2,200 5,239,832      
Issuance of common stock in exchange for debt $ 118,664 106,595 225,259
Issuance of common stock in exchange for debt, shares     118,663,761      
Issuance of common stock for cash     $ 136 30,389 30,525
Issuance of common stock for cash, shares     136,016      
Net loss         (116,615) (116,615)
Ending balance, value at Mar. 31, 2022 $ 6 $ 2 $ 124,040 9,311,776 (9,383,678) 52,146
Shares, Outstanding, Ending Balance at Mar. 31, 2022 6,000 2,200 124,039,609      
Ending balance, value at Mar. 31, 2022 $ 6 $ 2 $ 124,040 9,311,776 (9,383,677) 52,147
Beginning balance, value at Dec. 31, 2021 $ 6 $ 2 $ 54,138 9,246,631 (9,359,730) (58,953)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021 6,000 2,200 54,137,647      
Issuance of common stock in exchange for debt $ 69,863 59,383 129,246
Issuance of common stock in exchange for debt, shares     69,863,296      
Issuance of common stock for cash     $ 39 5,762 5,801
Issuance of common stock for cash, shares     38,666      
Net loss (23,948) (23,948)
Ending balance, value at Mar. 31, 2022 $ 6 $ 2 $ 124,040 9,311,776 (9,383,678) 52,146
Shares, Outstanding, Ending Balance at Mar. 31, 2022 6,000 2,200 124,039,609      
Ending balance, value at Mar. 31, 2022 $ 6 $ 2 $ 124,040 9,311,776 (9,383,677) 52,147
Beginning balance, value at Jun. 30, 2022 $ 6 $ 2 $ 124,431 9,362,205 (9,418,947) 67,697
Shares, Outstanding, Beginning Balance at Jun. 30, 2022 6,000 2,200 124,430,534      
Issuance of common stock for cash $ 824 74,110   74,934
Issuance of common stock for cash, shares     824,869      
Net loss         (207,446) (207,446)
Shares, Outstanding, Ending Balance at Mar. 31, 2023 6,000 2,200 125,255,403      
Ending balance, value at Mar. 31, 2023 $ 6 $ 2 $ 125,255 9,436,315 (9,626,393) (64,815)
Beginning balance, value at Dec. 31, 2022 6 2 $ 125,222 9,434,348 (9,603,736) (44,158)
Shares, Outstanding, Beginning Balance at Dec. 31, 2022     125,222,070      
Issuance of common stock for cash $ 33 1,967 2,000
Issuance of common stock for cash, shares     33,333      
Net loss (22,657) (22,657)
Shares, Outstanding, Ending Balance at Mar. 31, 2023 6,000 2,200 125,255,403      
Ending balance, value at Mar. 31, 2023 $ 6 $ 2 $ 125,255 $ 9,436,315 $ (9,626,393) $ (64,815)
v3.23.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (207,446) $ (116,615)
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on change in fair value of debt   1,700
Impairment of long-lived assets 115,000
Amortization 2,997
Changes in operating assets and liabilities:    
Accounts payable and accrued expenses 1,110 1,214
Net Cash Used In Operating Activities (88,339) (113,701)
CASH FLOWS  FROM INVESTING ACTIVITIES    
Patent costs (4,178)
Net Cash Used In Investing Activities (4,178)
CASH FLOWS FROM FINANCING ACTIVITIES    
Advances from related parties 17,916 60,854
Increase in common stock payable 15,334
Issuance of common stock for cash 74,934 30,525
Net Cash Provided By Financing Activities 92,850 106,713
Net increase (decrease) in cash 333 (6,988)
Cash - beginning of period 206 7,350
Cash - end of period 539 362
Cash paid during the year/period for:    
Interest
Taxes
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Issuance of common stock in exchange for debt $ 225,259
v3.23.2
ORGANIZATION, DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION
9 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION, DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

NOTE 1- ORGANIZATION, DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION

 

Background

 

GHST World Inc. (“the Company”), is a Delaware corporation that was incorporated on November 12, 1999.

 

The Company is a holding company for various technology and other activities. The Company has acquired and is developing several patents in the technology sector.

 

Basis of Presentation

 

The interim unaudited financial statements included herein have been prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission. In management's opinion, all adjustments (consisting of normal recurring adjustments and reclassifications) necessary to present fairly our results of operations and cash flows for the three and nine months ended March 31, 2023 and 2022, and our financial position as of March 31, 2023, have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year.

 

Certain information and disclosures normally included in the notes to the annual financial statements have been condensed or omitted from these interim financial statements. Accordingly, these interim unaudited financial statements should be read in conjunction with the financial statements and notes thereto for the year ended June 30, 2022.

 

v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Liquidity and Going Concern

 

The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company had net losses of $207,446 and $116,615 for the nine months ended March 31, 2023 and 2022. The Company has an accumulated deficit of $9,626,393 and a stockholders ‘deficit of $64,815 as of March 31, 2023 and used $88,339 and $113,701 in cash flow from operating activities for the nine months ended March 31, 2023 and 2022.

 

Management believes these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the next twelve months from the date these financial statements were issued. The ability to continue as a going concern is dependent upon profitable future operations, positive cash flows, and additional financing. These financial statements do not include any adjustments related to the recovery and classification of recorded asset amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Management intends to raise money through investors as needed to support its working capital needs. Currently the Company intends to raise capital from its existing shareholders. Management cannot provide any assurances that the Company will be successful in completing these undertakings and accomplishing any of its plans.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the following inactive wholly owned subsidiaries:

 

·GHST Art World, Inc
·GHST Sport Inc.
·IoTT world Inc.

 

All intercompany balances and transactions have been eliminated in consolidation.

 

Concentration of Credit Risk

 

The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash. The Company places its cash with financial institutions of high credit worthiness. At times, its cash with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it is a credit counterparty, and as such, it believes that any associated credit risk exposures are limited.

 

Foreign Currency

 

Transaction gains and losses are recognized in earnings. The Company is subject to foreign exchange rate fluctuations in connection with the Company’s international transactions as certain vendor payments and repayments of related party advances are done in foreign currency.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

 

Such estimates and assumptions impact, among others, the following: the valuation of other assets and patents, the fair value of share-based payments and deferred taxes.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.

 

Cash

Cash are amounts held at banks. The Company had no cash equivalents at March 31, 2023 or 2022.

Risks and Uncertainties

The Company is undertaking a new business venture that is inherently subject to significant risks and uncertainties, including financial, operational, technological and other risks that could potentially have a risk of business failure.

Fair Value

The carrying value of cash, other asset, accounts and other payable approximate their fair value based on the liquidity or the short-term maturities of these instruments. The fair value hierarchy promulgated by GAAP consists of three levels:

 

·Level one — Quoted market prices in active markets for identical assets or liabilities;
·Level two — Inputs other than level one inputs that are either directly or indirectly observable; and
·Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

 

Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company has no assets or liabilities that are measured at fair value on a recurring and/or non-recurring during the nine months ended March 31, 2023 and 2022.

 

Intangible Assets

 

The Company capitalizes external costs, such as filing fees and associated attorney fees, incurred to obtain issued patents and patent license rights. The Company expenses costs associated with maintaining and defending patents subsequent to their issuance in the period incurred. Once a patent is granted, the Company will amortize capitalized patent costs for internally generated patents on a straight-line basis over seven years, which represents the estimated useful lives of the patents. Amortization is recorded on a straight-line basis over the seven-year estimated useful life. The seven-year estimated useful life for internally generated patents is based on management’s assessment of such factors as the integrated nature of the portfolios being licensed, the overall makeup of the portfolio over time, and the length of license agreements for such patents. The Company assesses the potential impairment to all capitalized net patent cost when events or changes in circumstances indicate that the carrying amount of its patent portfolio may not be recoverable. 

Impairment of Long-Lived Assets

 

The Company accounts for impairment of long-lived assets in accordance with Accounting Standards Codification (“ASC”) 360, Property, Plant and Equipment, (“ASC 360”). Long-lived assets for the Company consist primarily of other assets and patents. In accordance with ASC 360, the Company periodically evaluates long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When triggering event indicators are present, the Company obtains appraisals on an asset by asset basis and will recognize an impairment loss when the sum of the appraised values is less than the carrying amounts of such assets. The appraised values, based on reasonable and supportable assumptions and projections, require subjective judgments. Depending on the assumptions and estimates used, the appraised values projected in the evaluation of long-lived assets can vary within a range of outcomes. The appraisals consider the likelihood of possible outcomes in determining the best estimate for the value of the assets. 

Income Taxes

 

Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and the respective tax bases. Deferred tax assets, including tax loss and credit carryforwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The effect of income tax positions is recognized only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.

 

Stock Based Compensation

 

The Company applies the fair value method of ASC 718, Share Based Payment, in accounting for its stock-based compensation. This accounting standard states that compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period, if any. As the Company does not have sufficient, reliable, and readily determinable values relating to its common stock, the Company has used the stock value pursuant to its most recent sale of stock for purposes of valuing stock-based compensation.

Net Loss Per Share

 

Basic net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the periods presented. Diluted net loss per common share is computed using the weighted average number of common shares outstanding for the period, and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options, stock warrants, convertible debt instruments or other common stock equivalents. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive.. The Company had no potentially dilutive securities outstanding for the three and six months ended March 31, 2023 or 2022.

 

Recent Accounting Pronouncements

 

There are no other recent accounting pronouncements that are expected to have a material effect on the Company's financial statements.

 

v3.23.2
OTHER ASSETS
9 Months Ended
Mar. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
OTHER ASSETS

NOTE 3 – OTHER ASSETS

 

On June 29, 2019, the Company acquired all the stock of GHST Art World, Inc, a Florida corporation, whose primary assets consisted of 119 art paintings and reproductions. The Company issued 43,478,000 shares of common stock and paid $15,000 in cash to effectuate the acquisition. The Company valued the stock at the fair market value of the stock on the date of issuance or approximately $0.0023 per share for a total purchase price of $115,000. The entire purchase price was allocated to the art and no goodwill was recorded.

 

On September 30, 2022, the Company’s management determined that the carrying value of the assets are impaired as there has been no third-party sales of such art work since acquisition and the planned business activity relating to such art work has been delayed. As a result, the Company has recorded an impairment loss of $115,000 for the six months ended March 31, 2023.

 

v3.23.2
PATENTS
9 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
PATENTS

NOTE 4 – PATENTS

 

The Company obtained a patent dated June 30, 2020, which is a protection device used in sporting activity with the capability to monitor data from the device. The Company has capitalized the patent costs totaling $40,362 and $39,181 as of March 31, 2023, and June 30, 2022. The Company started amortizing the patent during the three months ended December 31, 2022 over the seven-year useful life of the patent. Amortization was $2,998 was recorded for the three months ended March 31, 2023.

 

Schedule of patents        
   March 31, 2023   June 30,
2022
 
Patents  $43,359   $39,181 
Accumulated amortization   2,997     
Patents, net  $40,362   $39,181 

 

v3.23.2
COMMON STOCK PAYABLE
9 Months Ended
Mar. 31, 2023
Common Stock Payable  
COMMON STOCK PAYABLE

NOTE 5 – COMMON STOCK PAYABLE

 

The Company has an agreement with certain investors to convert their investment into common stock of the Company at a price equal to the average value of the stock over the previous six months. The conversion was contingent on the Company effectuating a 1-for-100 reverse stock split which was effected on September 30, 2021. As of March 31, 2023, and June 30, 2022, the Company has a total of $9,559 that has not been converted to common stock.

 

During the year ended June 30, 2022 certain investors accepted a total of 118,663,761 shares at an average price of approximately $0.0019 in exchange for $225,259 of debt which was classified as common stock payable.

v3.23.2
RELATED PARTY TRANSACTIONS
9 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 6 – RELATED PARTY TRANSACTIONS

 

At March 31, 2023 and June 30, 2022, the Company owed related parties a total of $93,362 and $75,446, respectively. These shareholder loans are unsecured, non-interest bearing and are due on demand.

 

As shown in Note 5, the Company has committed to converting certain debts to equity. Included in the debts is $9,559 as of March 31, 2023, of amounts due to related parties that will be converted as described in Note 5.

 

v3.23.2
STOCKHOLDERS’ EQUITY
9 Months Ended
Mar. 31, 2023
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 7 – STOCKHOLDERS’ EQUITY

 

On August 7, 2021, the board approved amending its articles of incorporation to reduce the number of authorized shares from 700,000,000 to 310,000,000 of which 300,000,000 are reserved for common stock and 10,000,000 for preferred stock.

 

Common Stock Issuances

 

During the nine months ended March 31, 2023, the Company issued 824,869 shares in exchange for $74,934 at an average price of $0.09.

 

v3.23.2
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 8. COMMITMENTS AND CONTINGENCIES

 

Legal Matters

 

From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of March 31, 2023, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the result of our operations.

 

On February 7, 2023, the Company entered into an agreement with a vendor to develop the technology associated with the Company’s patent for shin guards used in sports. The contract was for $46,000, but management decided to cancel the contract in favor of other potential vendors that the Company is studying closely.

 

v3.23.2
SUBSEQUENT EVENTS
9 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 9 – SUBSEQUENT EVENTS

The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements were issued for potential recognition or disclosure. Other than below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated financial statements. In April 2023 the Company formed a new wholly-owned subsidiary, InSSIDe World, Inc.

v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Liquidity and Going Concern

Liquidity and Going Concern

 

The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company had net losses of $207,446 and $116,615 for the nine months ended March 31, 2023 and 2022. The Company has an accumulated deficit of $9,626,393 and a stockholders ‘deficit of $64,815 as of March 31, 2023 and used $88,339 and $113,701 in cash flow from operating activities for the nine months ended March 31, 2023 and 2022.

 

Management believes these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the next twelve months from the date these financial statements were issued. The ability to continue as a going concern is dependent upon profitable future operations, positive cash flows, and additional financing. These financial statements do not include any adjustments related to the recovery and classification of recorded asset amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Management intends to raise money through investors as needed to support its working capital needs. Currently the Company intends to raise capital from its existing shareholders. Management cannot provide any assurances that the Company will be successful in completing these undertakings and accomplishing any of its plans.

 

Principles of Consolidation

Principles of Consolidation

 

The consolidated financial statements include the accounts of the following inactive wholly owned subsidiaries:

 

·GHST Art World, Inc
·GHST Sport Inc.
·IoTT world Inc.

 

All intercompany balances and transactions have been eliminated in consolidation.

 

Concentration of Credit Risk

Concentration of Credit Risk

 

The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash. The Company places its cash with financial institutions of high credit worthiness. At times, its cash with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it is a credit counterparty, and as such, it believes that any associated credit risk exposures are limited.

 

Foreign Currency

Foreign Currency

 

Transaction gains and losses are recognized in earnings. The Company is subject to foreign exchange rate fluctuations in connection with the Company’s international transactions as certain vendor payments and repayments of related party advances are done in foreign currency.

 

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

 

Such estimates and assumptions impact, among others, the following: the valuation of other assets and patents, the fair value of share-based payments and deferred taxes.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.

 

Cash

Cash

Cash are amounts held at banks. The Company had no cash equivalents at March 31, 2023 or 2022.

Risks and Uncertainties

Risks and Uncertainties

The Company is undertaking a new business venture that is inherently subject to significant risks and uncertainties, including financial, operational, technological and other risks that could potentially have a risk of business failure.

Fair Value

Fair Value

The carrying value of cash, other asset, accounts and other payable approximate their fair value based on the liquidity or the short-term maturities of these instruments. The fair value hierarchy promulgated by GAAP consists of three levels:

 

·Level one — Quoted market prices in active markets for identical assets or liabilities;
·Level two — Inputs other than level one inputs that are either directly or indirectly observable; and
·Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

 

Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company has no assets or liabilities that are measured at fair value on a recurring and/or non-recurring during the nine months ended March 31, 2023 and 2022.

 

Intangible Assets

Intangible Assets

 

The Company capitalizes external costs, such as filing fees and associated attorney fees, incurred to obtain issued patents and patent license rights. The Company expenses costs associated with maintaining and defending patents subsequent to their issuance in the period incurred. Once a patent is granted, the Company will amortize capitalized patent costs for internally generated patents on a straight-line basis over seven years, which represents the estimated useful lives of the patents. Amortization is recorded on a straight-line basis over the seven-year estimated useful life. The seven-year estimated useful life for internally generated patents is based on management’s assessment of such factors as the integrated nature of the portfolios being licensed, the overall makeup of the portfolio over time, and the length of license agreements for such patents. The Company assesses the potential impairment to all capitalized net patent cost when events or changes in circumstances indicate that the carrying amount of its patent portfolio may not be recoverable. 

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

The Company accounts for impairment of long-lived assets in accordance with Accounting Standards Codification (“ASC”) 360, Property, Plant and Equipment, (“ASC 360”). Long-lived assets for the Company consist primarily of other assets and patents. In accordance with ASC 360, the Company periodically evaluates long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When triggering event indicators are present, the Company obtains appraisals on an asset by asset basis and will recognize an impairment loss when the sum of the appraised values is less than the carrying amounts of such assets. The appraised values, based on reasonable and supportable assumptions and projections, require subjective judgments. Depending on the assumptions and estimates used, the appraised values projected in the evaluation of long-lived assets can vary within a range of outcomes. The appraisals consider the likelihood of possible outcomes in determining the best estimate for the value of the assets. 

Income Taxes

Income Taxes

 

Deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and the respective tax bases. Deferred tax assets, including tax loss and credit carryforwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred income tax expense represents the change during the period in the deferred tax assets and deferred tax liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The effect of income tax positions is recognized only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.

 

Stock Based Compensation

Stock Based Compensation

 

The Company applies the fair value method of ASC 718, Share Based Payment, in accounting for its stock-based compensation. This accounting standard states that compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period, if any. As the Company does not have sufficient, reliable, and readily determinable values relating to its common stock, the Company has used the stock value pursuant to its most recent sale of stock for purposes of valuing stock-based compensation.

Net Loss Per Share

Net Loss Per Share

 

Basic net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the periods presented. Diluted net loss per common share is computed using the weighted average number of common shares outstanding for the period, and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options, stock warrants, convertible debt instruments or other common stock equivalents. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive.. The Company had no potentially dilutive securities outstanding for the three and six months ended March 31, 2023 or 2022.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

There are no other recent accounting pronouncements that are expected to have a material effect on the Company's financial statements.

 

v3.23.2
PATENTS (Tables)
9 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
PATENTS
Schedule of patents        
   March 31, 2023   June 30,
2022
 
Patents  $43,359   $39,181 
Accumulated amortization   2,997     
Patents, net  $40,362   $39,181 
v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Jun. 30, 2022
Dec. 31, 2021
Jun. 30, 2021
Accounting Policies [Abstract]                
Net loss $ 22,884 $ 23,948 $ 207,446 $ 116,615        
Accumulated deficit 9,626,393   9,626,393     $ 9,418,947    
Stockholders' Deficit 64,815 (52,147) 64,815 (52,147) $ 44,158 $ (67,697) $ 58,953 $ 87,022
Cash Used In Operating Activities     88,339 113,701        
Cash equivalents $ 0 $ 0 $ 0 $ 0        
Potentially dilutive shares 0 0 0 0        
v3.23.2
OTHER ASSETS (Details Narrative) - USD ($)
9 Months Ended
Jun. 29, 2019
Mar. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Stock issued for acquisition, shares 43,478,000  
Cash paid for acquisition $ 15,000  
Share price $ 0.0023 $ 0.09
Stock issued for acquisition, value $ 115,000  
Impairment loss on other assets   $ 115,000
v3.23.2
PATENTS (Details) - USD ($)
Mar. 31, 2023
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
Patents $ 43,359 $ 39,181
Accumulated amortization 2,997
Patents, net $ 40,362 $ 39,181
v3.23.2
PATENTS (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2023
Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]    
Patent costs $ 43,359 $ 39,181
Amortization of intangible assets 2,998  
Patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Patent costs $ 40,362 $ 39,181
v3.23.2
COMMON STOCK PAYABLE (Details Narrative) - USD ($)
12 Months Ended
Sep. 30, 2021
Aug. 07, 2021
Jun. 30, 2022
Mar. 31, 2023
Jun. 29, 2019
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Revers stock split 1-for-100 On August 7, 2021, the board approved amending its articles of incorporation to reduce the number of authorized shares from 700,000,000 to 310,000,000      
Common stock payable     $ 9,559 $ 9,559  
Share price       $ 0.09 $ 0.0023
Investor [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Issuance of shares in exchange of debt shares     118,663,761    
Share price     $ 0.0019    
Issuance of shares in exchange of debt     $ 225,259    
v3.23.2
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
Mar. 31, 2023
Jun. 30, 2022
Related Party Transactions [Abstract]    
Advances from related parties $ 93,362 $ 75,446
Common stock payable - related parties $ 9,559  
v3.23.2
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2021
Aug. 07, 2021
Mar. 31, 2023
Jun. 29, 2019
Equity [Abstract]        
Stockholders' Equity, Reverse Stock Split 1-for-100 On August 7, 2021, the board approved amending its articles of incorporation to reduce the number of authorized shares from 700,000,000 to 310,000,000    
Common Stock, Capital Shares Reserved for Future Issuance   300,000,000    
Preferred Stock, Capital Shares Reserved for Future Issuance   10,000,000    
Stock issued during the period, shares     824,869  
Proceeds from issuance of stock     $ 74,934  
Price per share     $ 0.09 $ 0.0023
v3.23.2
COMMITMENTS AND CONTINGENCIES (Details Narrative)
Feb. 07, 2023
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Conctract cancel amount $ 46,000

GHST World (PK) (USOTC:GHST)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more GHST World (PK) Charts.
GHST World (PK) (USOTC:GHST)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more GHST World (PK) Charts.